| pubmed-article:17682989 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17682989 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17682989 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17682989 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:17682989 | lifeskim:mentions | umls-concept:C0339963 | lld:lifeskim |
| pubmed-article:17682989 | lifeskim:mentions | umls-concept:C1704410 | lld:lifeskim |
| pubmed-article:17682989 | lifeskim:mentions | umls-concept:C0936148 | lld:lifeskim |
| pubmed-article:17682989 | lifeskim:mentions | umls-concept:C0205221 | lld:lifeskim |
| pubmed-article:17682989 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17682989 | pubmed:dateCreated | 2007-8-8 | lld:pubmed |
| pubmed-article:17682989 | pubmed:abstractText | Coccidioidomycosis can be difficult to treat with available therapies, particularly in patients with progressive or disseminated disease. Posaconazole is a new azole antifungal with potent activity against Coccidioides species, the causative agent of coccidioidomycosis. | lld:pubmed |
| pubmed-article:17682989 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17682989 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17682989 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17682989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17682989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17682989 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17682989 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17682989 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17682989 | pubmed:issn | 1537-6591 | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:StevensDavid... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:CloudGretchen... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:CatanzaroAnto... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:LevineBernard... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:GalgianiJohn... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:MirelsLaurenc... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:WilliamsPaul... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:JohnsonRoyce... | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:RendonAdrianA | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:LutzJon EJE | lld:pubmed |
| pubmed-article:17682989 | pubmed:author | pubmed-author:HollowayMelis... | lld:pubmed |
| pubmed-article:17682989 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17682989 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17682989 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:17682989 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17682989 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17682989 | pubmed:pagination | 562-8 | lld:pubmed |
| pubmed-article:17682989 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:meshHeading | pubmed-meshheading:17682989... | lld:pubmed |
| pubmed-article:17682989 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17682989 | pubmed:articleTitle | Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. | lld:pubmed |
| pubmed-article:17682989 | pubmed:affiliation | University of California San Diego, San Diego, CA 92103, USA. acatanzaro@ucsd.edu | lld:pubmed |
| pubmed-article:17682989 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17682989 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:17682989 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17682989 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17682989 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17682989 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17682989 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17682989 | lld:pubmed |
